Publications

Publications

  1. Yang Y, Ishak Gabra MB, Hanse EA, Lowman XH, Tran TQ, Li H, Milman N, Liu J, Reid MA, Locasale JW, Gil Z, Kong M. MiR-135 suppresses glycolysis and promotes pancreatic cancer cell adaptation to metabolic stress by targeting phosphofructokinase-1. Nat Commun. 2019;10(1):809. doi: 10.1038/s41467-019-08759-0. PMID: 30778058; PMCID: PMC6379428.
  2. Amit, M., Na'ara, S., Fridman, E., Vladovski, E., Wasserman, T., Milman, N. and Gil, Z. RET, a targetable driver of pancreatic adenocarcinoma. Int. J. Cancer 2019;144: 3014-3022. https://doi.org/10.1002/ijc.32040
  3. Goshen-Lago T, Szwarcwort-Cohen M, Benguigui M, et al. The Potential Role of Immune Alteration in the Cancer-COVID19 Equation-A Prospective Longitudinal Study. Cancers (Basel). 2020;12(9):E2421. Published 2020 Aug 26. doi:10.3390/cancers12092421
  4. Erez Hasnis, Hyungsoo Kim, Sachin Verma, Yongmei Feng, Ronit Almog, Sivan Matsliah, Vera Vavinskaya, Ron Apelbaum, Offir Ben-Ishay, David Tuveson, Rosalie Sears, Ze’ev A. Ronai. Regulation of HDAC2-PDX1 by RNF125 defines pancreatic cancer development. bioRxiv 2020.01.06.896555; doi: doi.org/10.1101/2020.01.06.896555
  5. Sarvin, B, Lagziel, S, Sarvin, N et al. Fast and sensitive flow-injection mass spectrometry metabolomics by analyzing sample-specific ion distributions. Nat Commun 2020;11, 3186. https://doi.org/10.1038/s41467-020-17026-6
  6. Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368(6494):973-980. doi:10.1126/science.aay9189
  7. Khateb A, Deshpande A, Feng Y, Finlay D, Lee JS, Lazar I, Fabre B, Li Y, Fujita Y, Zhang T, Yin J, Pass I, Livneh I, Jeremias I, Burian C, Mason JR, Almog R, Horesh N, Ofran Y, Brown K, Vuori K, Jackson M, Ruppin E, Deshpande AJ, Ronai ZA. The ubiquitin ligase RNF5 determines acute myeloid leukemia growth and susceptibility to histone deacetylase inhibitors. Nat Commun. 2021;12(1):5397. doi: 10.1038/s41467-021-25664-7. PMID: 34518534; PMCID: PMC8437979.
  8. Magidey-Klein K, Cooper TJ, Kveler K, et al. IL-6 contributes to metastatic switch via the differentiation of monocytic-dendritic progenitors into prometastatic immune cells. Journal for ImmunoTherapy of Cancer 2021;9:e002856. doi:10.1136/jitc-2021-002856
  9. Khateeb D, Gabrieli T, Sofer B, Hattar A, Cordela S, Chaouat A, Spivak I, Lejbkowicz I, Almog R, Mandelboim M, Bar-On A. SARS-CoV-2 variants with reduced infectivity and varied sensitivity to the BNT162b2 vaccine are developed during the course of infection. PLoS Pathog. 2022;18(1):e1010242. doi: 10.1371/journal.ppat.1010242. PMID: 35020754; PMCID: PMC8789181.
  10. Aswad M, Hamza H, Pechkovsky A, Zikrach A, Popov T, Zohar Y, Shahar E, Louria-Hayon I. High-CBD Extract (CBD-X) Downregulates Cytokine Storm Systemically and Locally in Inflamed Lungs. Front Immunol. 2022;13:875546. doi: 10.3389/fimmu.2022.875546. PMCID: PMC9149302.
  11. Mandel I, Haves Ziv D, Goldshtein I, et al. BND-22, a first-in-class humanized ILT2-blocking antibody, promotes antitumor immunity and tumor regression. Journal for ImmunoTherapy of Cancer 2022;10:e004859. doi: 10.1136/jitc-2022-004859
  12. Krinsky N, Sizikov S, Nissim S, et al. NETosis induction reflects COVID-19 severity and Long COVID: insights from a two-center patient cohort study in Israel. J Thromb Haemost. 2023;11:S1538-7836(23)00274-X. doi: 10.1016/j.jtha.2023.02.033. Epub ahead of print. PMID: 37054916; PMCID: PMC10088279.J

 

Publications